Citation Impact

Citing Papers

Effects of Topical Anti-Inflammatory Agents in A Botulinum Toxin B—Induced Mouse Model of Keratoconjunctivitis Sicca
2007
Oral Azithromycin for Treatment of Posterior Blepharitis
2011
Alternatives to corneal transplantation for the management of bullous keratopathy
2014
Corneal Toxicity From Topical Ocular and Systemic Medications
2006
Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease
2016
TFOS DEWS II Clinical Trial Design Report
2017
Is it safe to use topical NSAIDs for corneal sensitivity in Sjögren’s syndrome patients?
2006
Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use
2009
Nonobvious Obstructive Meibomian Gland Dysfunction
2010
Ocular manifestations of graft-versus-host disease
2013
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, dexamethasone 0.1% alone, and vehicle in the treatment of subjects with blepharitis
2016
Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease
2016
Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)
2015
Infectious Keratitis Progressing to Endophthalmitis
2012
TFOS DEWS II Diagnostic Methodology report
2017 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
2017
Topical Nonsteroidal Anti-Inflammatory Therapy in Ophthalmology
2003
TFOS DEWS II pathophysiology report
2017 Standout
Topical Azithromycin and Oral Doxycycline Therapy of Meibomian Gland Dysfunction
2012
TFOS DEWS II Epidemiology Report
2017 Standout
Topical Nonsteroidal Anti-Inflammatory Drugs for Ophthalmic Use
2002
Multicenter Open-Label Study Evaluating the Efficacy of Azithromycin Ophthalmic Solution 1% on the Signs and Symptoms of Subjects With Blepharitis
2010
TFOS DEWS II Definition and Classification Report
2017 Standout
Minocycline Controls Clinical Outcomes and Inflammatory Cytokines in Moderate and Severe Meibomian Gland Dysfunction
2012
Ocular surface damage by ophthalmic compounds
2011
TFOS DEWS II Management and Therapy Report
2017 Standout
TFOS DEWS II iatrogenic report
2017
Corneal nerves in health and disease
2014
Nocturnal Lagophthalmos: An Overview and Classification
2006
Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis
2012
Treatment of Blepharitis: Recent Clinical Trials
2014
Compliance and Subjective Patient Responses to Eyelid Hygiene
2016
Topical Azithromycin Therapy for Meibomian Gland Dysfunction: Clinical Response and Lipid Alterations
2010
Ulcerative colitis
2020 Standout
Impact of dry eye disease and treatment on quality of life
2010
Baseline Factors Predictive of Visual Prognosis in Acute Postoperative Bacterial Endophthalmitis in Patients Undergoing Cataract Surgery
2013
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients
2004
Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use
2007
A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients with Moderate Dry Eye Disease
2016
The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Interactions With the Tear Film Subcommittee
2013
Emerging therapeutics for ocular surface disease
2016
Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis
2010
Meibomian Gland Dysfunction Model in Hairless Mice Fed a Special Diet With Limited Lipid Content
2016
Digital eye strain: prevalence, measurement and amelioration
2018 Standout
Cataract Drug Delivery Systems (Dropless vs. Nondropless Cataract Surgery)
2016
Corneal collagen crosslinking: a systematic review.
2014 Standout
Interventions for chronic blepharitis
2012
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease
2016
The International Workshop on Meibomian Gland Dysfunction: Report of the Diagnosis Subcommittee
2011
Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics
2019
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction
2011 Standout
Cataracts
2017 Standout
The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee
2011 Standout
Corneal surface glycosylation is modulated by IL‐1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding
2017 StandoutNobel

Works of Jodi Luchs being referenced

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease
2018
Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease
2015
Visual Outcome and Bacterial Sensitivity After Methicillin-Resistant Staphylococcus aureus–Associated Acute Endophthalmitis
2008
Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs
2001
Sensitivity and Specificity of the AdenoPlus Test for Diagnosing Adenoviral Conjunctivitis
2013
Azithromycin in DuraSite® for the treatment of blepharitis
2010
Ulcerative Keratitis in Bullous Keratopathy
1997
Lifitegrast for the Treatment of Dry Eye Disease
2016
Efficacy of Hydroxypropyl Cellulose Ophthalmic Inserts (LACRISERT) in Subsets of Patients With Dry Eye Syndrome: Findings From a Patient Registry
2010
Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis
2008
Rankless by CCL
2026